2013 Third-quarter Revenue

• Revenue up 2.2% for the first nine months of the year
• The third quarter has been strongly impacted by the slowdown of the Algerian automotive market
...

2013 Third-quarter Revenue
 

• Revenue up 2.2% for the first nine months of the year
• The third quarter has been strongly impacted by the slowdown of the Algerian automotive market 

In a statement, Alain Viry, Chairman of CFAO's Management Board said:

“Thanks to the solid growth of Eurapharma and the Industries, Equipment & Services division, CFAO posted 2.2% growth in the first nine months of the year. In the Automotive division, the slowdown in several markets, mainly in Algeria, has been accelerating over the third quarter resulting in a decline of the sales. In this new context, CFAO teams are taking targeted commercial and organizational actions and pursuing successfully the development of the healthcare and the consumer goods businesses.”

Please find attached the entire press release hereafter.